Comparative evaluation of different methods of correction of mucociliary transport (MCT) insufficiency in patients with chronic bronchitis (CB)

O. V. Gurzhiy (Dnepropetrovsk, Ukraine)

Source: Annual Congress 2006 - Implications of progressive airway obstruction
Session: Implications of progressive airway obstruction
Session type: Poster Discussion
Number: 3664
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. V. Gurzhiy (Dnepropetrovsk, Ukraine). Comparative evaluation of different methods of correction of mucociliary transport (MCT) insufficiency in patients with chronic bronchitis (CB). Eur Respir J 2006; 28: Suppl. 50, 3664

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mucociliary clearance (MCC) disorders in patient with acute bronchitis (AB) and acute exacerbation (AE) of COPD and ways of it correction
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


Does tolerance of neuro-muscular electrical stimulation (NMES) relate to gender in patients with an acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment
Year: 2012


Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012


Comparative analysis of rhythm disturbances in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018


The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection?
Source: Eur Respir J 2001; 18: Suppl. 33, 172s
Year: 2001

Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Prevalence rates of symptoms and diagnoses of chronic bronchitis (CB), emphysema (E) and asthma (A), with or without airflow obstruction (AO), in two Italian general population samples
Source: Eur Respir J 2005; 26: Suppl. 49, 595s
Year: 2005

Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Modeling of oxygen uptake kinetics during exercise testing in patients with chronic obstructive pulmonary diseases (COPD)
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Validation of CAT as an independent assessment tool in pulmonary rehabilitation (PR) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD
Year: 2012


Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010

Comparative evaluation of mucociliary clearance in patients with mucoviscedosis and chronic obstructive bronchitis and one influence of hypertonic sodium chloride concentrations on it
Source: Eur Respir J 2001; 18: Suppl. 33, 124s
Year: 2001

Changes of respiratory mechanics (RM) during exacerbations of chronic obstructive pulmonary disease (COPD) requiring noninvasive ventilation (NIV)
Source: Annual Congress 2010 - News from noninvasive ventilation
Year: 2010



Value of ²GOLD² reversibility test criteria in detecting ²reversible² chronic obstructive pulmonary disease (COPD) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004